Evaluation of Antithrombotic STrategies in STEMI Patients in China (EAST-STEMI)

Shandong University

Status: Unknown

Conditions: Emergent PCI; STEMI

Study type: Observational

Funder types: Other

Identifiers

NCT03510832

QLEmer201802

Details and patient eligibility

About

EAST-STEMI is the first perspective, multicenter, large-scale registry focusing on the evaluation of real-world medical quality (especially PCI quality) and antithrombotic strategies in STEMI patients undergoing emergent PCI in a regional representative sample in China with 2 years follow-up. Clinical decision support tools (including ischemic score, bleeding score, etc) will be developed and validated based on the database. Novel biomarkers to predict the prognosis and to support risk stratification will be explored by using the blood samples.

Enrollment: 8,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Age>=18yrs
2. STEMI patients undergoing emergent PCI
3. Signed informed consent

Exclusion criteria

1. Difficult to follow up or obtain accurate information (e.g., long-term overseas stay, speech or mental disorders)
2. Other severe diseases (e.g., liver failure, renal failure and advanced stage of cancer)

Trial design

8,000 participants in 1 patient group

STEMI patients undergoing Emergent PCI